Find an expert

Professor Michael Monteiro has established an international reputation in the field of 'living' radical polymerization to create complex polymer architectures. He is now building designer polymers for various biomedical applications, including vaccines, drug delivery and stem cells. He is dedicated to translating research into commercial outcomes, with 7 PCT and provisional patents since 2005 and start-up company DendriMed Pty Ltd. He was awarded an ARC QEII Fellowship in 2004 and an ARC Future Fellowship in 2009. He has attracted ARC and NHMRC grants; and Queensland State Government funding in excess of $7 million.

International links

Professor Monteiro has built a strong collaboration with Professor Virgil Percec from the University of Pennsylvania to develop and understand the new SET-LRP. He has developed a collaboration with Professor Rachel O'Reilly from the University of Warwick to develop nanoreactors that mimic enzyme activity. In collaboration with Professor Eugenia Kumacheva from the University of Toronto, they developed temperature responsive micron-sized particles from encapsulation of cells.

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy and Pharmaceutical Sciences at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Dr Shehzahdi (Sheb) Moonshi is a nanobiologist and translational immunology researcher at the University of Queensland’s Frazer Institute and Translational Research Institute (TRI). Her research focuses on developing antigen-specific immunotherapies (ASI) and nanoparticle-based precision medicines to treat autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.

At TRI (2025), she has translated this skillset to optimise antigen-specific liposomal nanotherapies for in vitro stability and evaluate their biodistribution and efficacy in vivo using preclinical models of autoimmune disease. She has also developed unique expertise in creating scalable, immune-targeted delivery platforms for clinical translation through close collaboration with a Clinical Drug Manufacturing Organisation for the scale-up and manufacture of ASITI-RA, a rheumatoid arthritis antigen-specific immunotherapy.

Her broader expertise spans:

• Nanomedicine formulation and characterisation

• Translational immunology and preclinical model development (humanised mice)

• Collaborative, consumer-partnered, and clinician-led translational research

Dr Moonshi’s goal is to advance precision immunotherapies that restore immune tolerance and transform outcomes for people with autoimmune and inflammatory diseases.

Paul Moore is a senior lecturer in the postgraduate Applied Linguistics program in The School of Languages and Cultures, specialising in Language and Technology and Sociocultural Theory. Paul’s main research interest involves the dynamic influence of learners, tasks and sociocultural context on task-based interaction, performance and development. Recent projects have included ecological CALL teacher training, sociocognitive interpretations of language test performance, language policy in higher education, and the intersection between language and intercultural communication.

Emeritus Prof Moore’s research interests include: history of Australia, Queensland, Pacific Islands, New Guinea, Papua New Guinea, and Solomon Islands,.

Emeritus Prof Moore holds a BA and PhD from James Cook University. His teaching at UQ covered Australia, Queensland, and the Pacific Islands, colonial and race relations history, and the history of gender and sexuality. He was Head of the School of History, Philosophy, Religion and Classics from 2008 to 2013.

Emeritus Prof Moore held the McCaughey Chair in History. He has been a member of the Board of the Journal of Pacific History since 1998. In 1999 he headed the Queensland team for the National Archives Founding Documents Webpage. During 2000-01 he served on a Panel of Enquiry into the restructure of the University of PNG and authored a UNESCO report on higher distance education in UPNG. In 2005 he was awarded a Cross of Solomon Islands for his work on Solomon Islands history. He was President of the Australian Association for the Advancement of Pacific Studies from 2006 to 2010 and was elected a Fellow of the Australian Academic of the Humanities in 2011.

He has contunued to research and publish on Solomon Islands and Queensland.

Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, a unique resource located on the Queensland Children's Hospital precinct, facilitating local, national and international collaborative research across all childhood cancer types and supporting enrolment of children on clinical trials. A/Prof. Moore's clinical and research interests focus on childhood leukaemia, particularly acute myeloid leukaemia (AML), an aggressive form of leukaemia with a poor prognosis. He also holds a number of leadership and advisory roles, including Deputy Chair of the Australian & New Zealand Childrens Haematology / Oncology Group (ANZCHOG).

Professor Moorhead works in late antique and early medieval history.

A graduate of the universities of New England and Liverpool, he is a Fellow of the Australian Academy of the Humanities and has walked the medieval pilgrim trail from Le Puy to Santiago.

Dr Moradi is an entomologist with extensive experience using novel technologies to control plant and animal insect pests. As a research scientist at DAF currently she is scoping out new projects to use flies as vectors of vaccines for livestock.she is also developing projects on using Nano technology for livestock exctosparsite control.

Prof Alina Morawska is Director of the Parenting and Family Support Centre, The University of Queensland. She is passionate about creating a world where children develop the skills, competencies and confidence to adapt and thrive in an ever-changing world. Her research focuses on the central role of parents in influencing all aspects of children’s development, and parenting interventions as a way of understanding healthy development, a means for promoting positive family relationships, and a tool for the prevention and early intervention in lifelong health and wellbeing. She has published extensively in the field of parenting and family intervention and has received numerous grants to support her research. She has been recognised as Australia’s top scholar in family studies.

Professor Matthew Morell has had an extensive career over four decades characterised by his focus on conducting and leading high-quality agricultural research that delivers benefits to the agriculture and food sectors, and to consumers. In leadership, Professor Morell has a track record in developing effective teams and working with institutions and their stakeholders to deliver innovations for the future.

As Director of QAAFI, Professor Morell is highly motivated by the opportunity to lead research programs that provide research and knowledge based solutions to many of the major big challenges of our times, including enhancing both profitability and sustainability in agricultural production, providing improved nutrition, building resilience in the face of climate change, and reducing the environmental footprint of agriculture, all in ways that protect and build the livelihoods of farmers and rural communities. The mission of QAAFI in providing benefits to Queensland through working closely with producers, the food industry, the Department of Agriculture and Fisheries, and other research partners and stakeholders across the state, provides a highly fertile ground for conducting and delivering research that makes a significant difference to Queensland and its people. QAAFI has an important role serving as a focal point for Queensland in engaging nationally and internationally with global efforts to find solutions to global challenges in agriculture and food production.

Over the past seven years, Professor Morell led research in an international development context at the International Rice Research Institute (IRRI) based in the Philippines. As IRRI’s CEO for the past five years, he led the institute’s affairs across 17 countries, set strategic direction in close consultation with its Board of Trustees, staff and stakeholders. Prior to his appointment as CEO, Professor Morell was IRRI’s Deputy Director General (Research), driving research and outreach programs across various dimensions of rice science including climate change-ready rice, healthier varieties, environmentally sustainable farming systems, and capacity development. In his leadership at IRRI, Professor Morell instilled a strong focus on both understanding and meeting the needs of stakeholders and beneficiaries, he strengthened IRRIs regional presence, particularly through the establishment of the IRRI South Asia Research Centre, and drove modernisation of the Institute's research operations to be more effective and efficient.

Before joining IRRI, Professor Morell worked for 17 years at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), where he initiated, developed, and led a research program on future grains and plant oil production. Dr Morell has extensive experience in working closely with industry and in identifying, protecting, and managing intellectual property. His work at CSIRO resulted in the formation of two spin off companies which have commercialised novel grains delivering human health benefits. He holds a PhD in agricultural chemistry from the University of Sydney; conducted postdoctoral studies at the University of Michigan and the University of California, Davis; and was a research fellow at the Australian National University. He is an Academy Fellow of the International Association of Cereal Chemists and of the Academy of Technological Sciences and Engineering of Australia. (ATSE).

Dr Michael Morgan is a mid-career academic with a robust foundation in basic sciences, who has built a distinguished path exploring the biological underpinnings of pain—particularly musculoskeletal pain and osteoarthritis. With influential lead author publications in PAIN, Osteoarthritis and Cartilage and Bone his work bridges molecular mechanisms and translational insights. Now pivoting toward clinical research, he is deepening his focus on another musculoskeletal condition, focusing on whiplash injury and the multidimensional nature of pain, driving cross-disciplinary studies that aim to connect lab findings with real-world patient outcomes.

Prof Morgan was the Director of the Centre for Hypersonics since its inception in 1997 until October 2021. He lectures in mechanical and aerospace engineering within the School of Mechanical and Mining Engineering.

He has a strong research record in the development of hypervelocity impulsive facilities on which the UQ Centre for Hypersonics research program is based, including the ‘X’ series of super-orbital expansion tubes, and has extensive experience in hypersonic aero-thermo-dynamics and scramjet propulsion.

Richard Morgan has been developing superorbital ground based facilities for many years, and has collaborative research program with DSTG, NASA, ESA, Oxford University, Ecole Centrale (Paris) and AOARD in radiating flows, as well as continuing ARC support in this area since 1990, including two current ARC Discovery grants in partnership with European and American partners.

He was involved as a flight team member in the 2010 airborne observation of the Japanese ‘Hayabusa’ asteroid sample return mission, for which he was a co-recipient of the NASA Ames ‘honour’ award for 2010. He regularly gives invited talks in international meetings, and gave a plenary presentation to the AIAA Hypersonic Spaceplanes Conference in San Francisco in April 2011.

Professor Richard Morgan was awarded a 2012 UQ Excellence in Research Higher Degree Supervision award for encouraging student development through international student exchanges with overseas collaborators, whilst engendering internal cooperation within the study body.

Courtney is a Research Fellow with CoralWatch at The University of Queensland, specialising in citizen science, biodiversity conservation, and human–environment interactions.

She supports a global citizen science program that tracks coral bleaching and reef health, working with schools, tourism operators, and community groups worldwide. She focuses on ensuring the program delivers high-quality environmental data while strengthening scientific literacy and fostering meaningful connections between people and the natural world.

Courtney also has extensive experience in tropical conservation, including research in sustainable palm oil production and biodiversity protection. This work has highlighted gaps between policy intent and on-ground outcomes, demonstrating the need for clearer metrics, stronger accountability, and improved implementation strategies.

Prof Karen Moritz is internationally renowned for her work in understanding how early life perturbations contribute to an increased risk of developing cardiovascular, renal and metabolic disease in adulthood. Over the last 5-7 years, her research has focused on determining how prenatal alcohol can result in “developmental programming” of disease. Her research has identified critical windows of susceptibility to alcohol, including the period around conception and prior to implantation. In addition, her work has identified the placenta as playing a key role in the sex-specific offspring outcomes following maternal perturbations. Her research spans both preclinical and clinical domains, highlighted by her appointment as the Director of the Child Health Research Centre in 2016.

Current projects are:

• Periconceptional alcohol exposure: Programming long-term health in offspring (with Dr Lisa Akison and Dr James Cuffe)

• Emerging therapies for diabetes and complications: Effects on metabolic, cardiovascular and renal function (with Dr Linda Gallo)

• Effect of prenatal insults on the developing placenta (with Dr Marloes Nitert Dekker, Prof Vicki Clifton [Mater], Dr David Simmons and Dr James Cuffe)

• Effect of prenatal insults on the developing kidney and implications for adult disease (with Dr Peter Trnka [QLD Children's Hospital])

• Impact of maternal cannabis and alcohol around conception on development and long-term health of offspring (with Dr David Simmons and Dr Lisa Akison)

Prof Moritz maintains a strong commitment to teaching of students, including lectures and research student supervision in undergraduate programs, supervision of Honours students and supervision of higher degree research students.